Formation of new blood vessels (angiogenesis) has been demonstrated to be a basic
prerequisite for sustainable growth and proliferation of tumor. Several growth factors …

Placental growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF)
family that also comprises VEGF-A (VEGF), VEGF-B, VEGF-C, and VEGF-D. Unlike VEGF …

Peripheral arterial disease (PAD) is a common vascular disease that reduces blood flow
capacity to the legs of patients. PAD leads to exercise intolerance that can progress in …

Plasma irradiation generates many factors able to affect the cellular condition, and this
feature has been studied for its application in the field of medicine. We previously reported …

Circulating levels of placental growth factor (PlGF) are significantly reduced in women who
develop preeclampsia. Low molecular weight heparin (LMWH) has been shown to acutely …

The venous system has been historically understudied despite its critical roles in blood
distribution, heart function, and systemic immunity. This study dissects the microanatomy of …

Placental growth factor (PLGF), a potent stimulator of arteriogenesis, is upregulated during
outward arterial remodeling. Increased fluid shear stress (FSS) is a key physiological …

Background: Placental growth factor (PGF) is important for wound‐healing and vascular
collaterogenesis. PGF deficiency is associated with preeclampsia, a hypertensive disease of …

Epithelial‐to‐mesenchymal transition (EMT) occurs frequently in lung epithelium in
response to damage stimuli, such as inflammation and oxidative stress. Our group has …

In tissues containing pre-existing collateral vessels, occlusion of an upstream supply artery
results in diversion of blood flow through these vessels, protecting the distal tissue from …